Portfolio
HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.
Overview as at 30 June 2025
Currency allocation of assets
Emphasis on US dollar investments
56
340
US dollar (USD)
53
Euro (EUR)
17
Renminbi (CNY)
12
Indian rupee (INR)
8
Swiss franc (CHF)
6
Other currencies (CAD, DKK, GBP, HDK, SEK)
4
#8aacb4
#3e395b
#ebbe1a
#a00f3b
#52755e
#8c74af
#00a4c8
#dc6c3f
#cab415
#423e3d
Allocation of assets
Mainly invested in private companies or in companies originating
from the private companies portfolio.
62
340
Private companies
33
Public (from private) companies
26
Public companies
22
Funds
10
Cash and cash equivalents
5
Other assets
4
#8aacb4
#3e395b
#ebbe1a
#a00f3b
#52755e
#8c74af
#00a4c8
#dc6c3f
#cab415
#423e3d
Development phase of portfolio companies
Mainly invested in revenue generating companies or in companies with products at an advanced stage of development.
69
90
Profitable
51
Products on the market
15
Phase I
5
Phase II
19
Phase III
8
Preclinical
2
#8aacb4
#3e395b
#ebbe1a
#a00f3b
#52755e
#8c74af
#00a4c8
#dc6c3f
#cab415
#423e3d
Therapeutic area of the lead product of portfolio companies
Broadly diversified areas of activity.
79
350
Others
34
Oncology
17
Synthetic biology
13
Central nervous system
12
Immunology/Inflammation
8
Orphan diseases
6
Digital Health
5
Medical technology / diagnostics
5
#8aacb4
#3e395b
#ebbe1a
#a00f3b
#52755e
#8c74af
#00a4c8
#dc6c3f
#cab415
#423e3d